Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)

NCT01186406 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped Study ended early due to toxicity

Conditions

Glioblastoma Multiforme
Gliosarcoma

Interventions

DRUG: Gliadel
RADIATION: Radiation Therapy
DRUG: Avastin
DRUG: Temodar

Sponsor

Duke University

Collaborators

[object Object]
[object Object]